Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions-Reference-Cited by-同舟云学术

Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions

Published:2016-07 Issue:1 Volume:138 Page:219-228.e9
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Weisser Maren,Demel Uta M.,Stein Stefan^ORCID,Chen-Wichmann Linping,Touzot Fabien,Santilli Giorgia,Sujer Stefanie,Brendel Christian,Siler Ulrich,Cavazzana Marina,Thrasher Adrian J.,Reichenbach Janine,Essers Marieke A.G.,Schwäble Joachim,Grez Manuel

Funder

Deutsche Forschungsgemeinschaft

European Union

Wellcome Trust

LOEWE Center for Cell and Gene Therapy

Hessische Ministerium für Wissenschaft und Kunst

Zurich Centre for Integrative Human Physiology

Ettore e Valeria Rossi Foundation

German Federal Ministry of Health

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. The genetic basis of chronic granulomatous disease;Roos;Immunol Rev,1994

2. The NADPH oxidase and chronic granulomatous disease;Segal;Mol Med Today,1996

3. Genetic, biochemical, and clinical features of chronic granulomatous disease;Segal;Medicine (Baltimore),2000

4. Chronic granulomatous disease: recent advances in pathophysiology and treatment;Seger;Neth J Med,2010

5. Chronic granulomatous disease and other disorders of phagocyte function;Dinauer;Hematology Am Soc Hematol Educ Program,2005

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. IL-1 in aging and pathologies of hematopoietic stem cells;Blood;2024-07-25

2. Reactive oxygen species and its role in pathogenesis and resistance to therapy in acute myeloid leukemia;Cancer Drug Resistance;2024-02-22

3. Haematopoietic stem cell health in sickle cell disease and its implications for stem cell therapies and secondary haematological disorders;Blood Reviews;2024-01

4. Removal of innate immune barriers allows efficient transduction of quiescent human hematopoietic stem cells;Molecular Therapy;2024-01

5. Myelodysplasia and transgene inactivation in X-CGD-γ retroviral gene therapy: The usual suspects and new players;Molecular Therapy;2023-12